Children and teenagers with hemophilia are considerably more physically active than adult patients, possibly reflecting more recent emphasis on the…
Articles by Diana Campelo Delgado
Sanofi has reduced the dosing of its investigational treatment fitusiran in clinical trials to lower the risk of blood…
Kovaltry (octocog alfa) is effective and safe as a preventive treatment for children with…
Rixubis safely and effectively prevents and manages bleeding in children and adults with hemophilia B, a real-world study from South…
The first participant was dosed with the investigational therapy marstacimab in a Phase 3 clinical trial — still…
A Phase 4 trial investigating Ixinity as a prophylactic treatment for children under age 12 with hemophilia B has reached…